Non-Melanoma Skin Cancers Coverage from Every Angle
Advertisement
Advertisement

Chrysalyne Schmults, MD, on Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma: Treatment Pipeline

Posted: Monday, April 1, 2019

Chrysalyne Schmults, MD, of Brigham and Women’s Hospital, discusses the recent approval of cemiplimab, similar agents in the pipeline, and other classes of drugs under study to treat metastatic or locally advanced cutaneous squamous cell cancer.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.